301207 华兰疫苗
午间休市 04-02 11:30:00
资讯
新帖
简况
华兰疫苗(301207)2025年年报简析:增收不增利
证券之星 · 03-29
华兰疫苗(301207)2025年年报简析:增收不增利
华兰疫苗(301207.SZ)发布2025年度业绩,归母净利润1.83亿元,下降10.99%
智通财经 · 03-27
华兰疫苗(301207.SZ)发布2025年度业绩,归母净利润1.83亿元,下降10.99%
股市必读:华兰疫苗(301207)股东户数2.7万户,较上期减少3.57%
证券之星 · 03-02
股市必读:华兰疫苗(301207)股东户数2.7万户,较上期减少3.57%
华兰疫苗(301207)2月13日股东户数2.7万户,较上期减少3.57%
证券之星 · 02-27
华兰疫苗(301207)2月13日股东户数2.7万户,较上期减少3.57%
华兰疫苗(301207)披露募集资金专项账户部分资金被冻结及解除冻结的公告,2月25日股价上涨1.14%
证券之星 · 02-25
华兰疫苗(301207)披露募集资金专项账户部分资金被冻结及解除冻结的公告,2月25日股价上涨1.14%
华兰疫苗(301207)1月31日股东户数2.8万户,较上期增加27.27%
证券之星 · 02-24
华兰疫苗(301207)1月31日股东户数2.8万户,较上期增加27.27%
华兰疫苗跌1.1% 2022年上市见顶募22.76亿元
中金财经 · 02-09
华兰疫苗跌1.1% 2022年上市见顶募22.76亿元
股市必读:华兰疫苗(301207)1月30日董秘有最新回复
证券之星 · 02-02
股市必读:华兰疫苗(301207)1月30日董秘有最新回复
华兰疫苗:截至2026年1月20日,公司股东人数为两万两千余人
中金财经 · 01-30
华兰疫苗:截至2026年1月20日,公司股东人数为两万两千余人
华兰疫苗跌9.05% 2022年上市见顶募22.76亿元
中金财经 · 01-29
华兰疫苗跌9.05% 2022年上市见顶募22.76亿元
华兰疫苗最新公告:公司尚无预防尼帕病毒相关的疫苗产品
证券之星 · 01-27
华兰疫苗最新公告:公司尚无预防尼帕病毒相关的疫苗产品
1月26日华兰疫苗(301207)龙虎榜数据:机构净买入1652.12万元,北向资金净买入203.06万元
证券之星 · 01-26
1月26日华兰疫苗(301207)龙虎榜数据:机构净买入1652.12万元,北向资金净买入203.06万元
异动快报:华兰疫苗(301207)1月26日9点57分触及涨停板
证券之星 · 01-26
异动快报:华兰疫苗(301207)1月26日9点57分触及涨停板
华兰疫苗跌2.3% 2022年上市见顶募22.76亿元
中金财经 · 01-16
华兰疫苗跌2.3% 2022年上市见顶募22.76亿元
流感疫情持续,防控系统工程再受考验
证券之星 · 2025-12-31
流感疫情持续,防控系统工程再受考验
华兰疫苗:流感疫苗占公司营收比例超90%
证券之星 · 2025-12-30
华兰疫苗:流感疫苗占公司营收比例超90%
华兰疫苗:流感疫苗批签发批次数量位居国内前列
证券之星 · 2025-12-12
华兰疫苗:流感疫苗批签发批次数量位居国内前列
华兰疫苗:截至目前已签发流感疫苗55批
证券之星 · 2025-11-28
华兰疫苗:截至目前已签发流感疫苗55批
华兰疫苗跌5.4% 2022年上市见顶募22.76亿元
中金财经 · 2025-11-17
华兰疫苗跌5.4% 2022年上市见顶募22.76亿元
华兰疫苗:流感疫苗批签发批次数量居国内前列
证券之星 · 2025-10-30
华兰疫苗:流感疫苗批签发批次数量居国内前列
加载更多
公司概况
公司名称:
华兰生物疫苗股份有限公司
所属行业:
医药制造业
上市日期:
2022-02-18
主营业务:
华兰生物疫苗股份有限公司的主营业务是人用疫苗研发、生产、销售。公司的主要产品是流感病毒裂解疫苗、四价流感病毒裂解疫苗、四价流感病毒裂解疫苗(儿童剂型)、甲型H1N1流感病毒裂解疫苗、ACYW135群脑膜炎球菌多糖疫苗、重组乙型肝炎疫苗(汉逊酵母)、A群C群脑膜炎球菌多糖疫苗、冻干人用狂犬病疫苗(Vero细胞)、吸附破伤风疫苗。公司核心产品的先发优势明显,公司研制出全球首批甲型H1N1流感病毒裂解疫苗,该产品获得国家科学技术部、国家质量监督检验检疫总局等机构联合颁发的“国家重点新产品”证书。
发行价格:
56.88
{"stockData":{"symbol":"301207","market":"SZ","secType":"STK","nameCN":"华兰疫苗","latestPrice":20.17,"timestamp":1775100600000,"preClose":20.08,"halted":0,"volume":6621787,"delay":0,"changeRate":0.0045,"floatShares":601000000,"shares":601000000,"eps":0.2668,"marketStatus":"午间休市","change":0.09,"latestTime":"04-02 11:30:00","open":19.97,"high":20.43,"low":19.85,"amount":133000000,"amplitude":0.0289,"askPrice":20.17,"askSize":9,"bidPrice":20.16,"bidSize":22,"shortable":0,"etf":0,"ttmEps":0.2668,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775106000000},"marketStatusCode":3,"adr":0,"adjPreClose":20.08,"symbolType":"stock","openAndCloseTimeList":[[1775093400000,1775100600000],[1775106000000,1775113200000]],"highLimit":22.09,"lowLimit":18.07,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":601027500,"isCdr":false,"pbRate":2.12,"roa":"--","peRate":75.5997,"roe":"3.08%","epsLYR":0.3074,"committee":0.124654,"marketValue":12123000000,"turnoverRate":0.011,"status":0,"floatMarketCap":12115000000},"requestUrl":"/m/hq/s/301207","defaultTab":"news","newsList":[{"id":"2623336843","title":"华兰疫苗(301207)2025年年报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2623336843","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623336843?lang=zh_cn&edition=full","pubTime":"2026-03-29 06:25","pubTimestamp":1774736723,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期华兰疫苗发布2025年年报。根据财报显示,华兰疫苗增收不增利。截至本报告期末,公司营业总收入12.03亿元,同比上升6.62%,归母净利润1.83亿元,同比下降10.99%。该数据低于大多数分析师的预期,此前分析师普遍预期2025年净利润为盈利7.24亿元左右。本次财报公布的各项数据指标表现一般。然而去年的净利率为15.21%,算上全部成本后,公司产品或服务的附加值高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900001824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622733827","title":"华兰疫苗(301207.SZ)发布2025年度业绩,归母净利润1.83亿元,下降10.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622733827","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622733827?lang=zh_cn&edition=full","pubTime":"2026-03-27 21:57","pubTimestamp":1774619822,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华兰疫苗(301207.SZ)发布2025年年度报告,该公司营业收入为12.03亿元,同比增长6.62%。归属于上市公司股东的净利润为1.83亿元,同比减少10.99%。归属于上市公司股东的扣除非经常性损益的净利润为1.32亿元,同比增长9.38%。基本每股收益为0.3074元。此外,拟向全体股东每10股派发现金红利8元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616287377","title":"股市必读:华兰疫苗(301207)股东户数2.7万户,较上期减少3.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616287377","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616287377?lang=zh_cn&edition=full","pubTime":"2026-03-02 01:40","pubTimestamp":1772386822,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,华兰疫苗报收于20.7元,上涨0.39%,换手率0.91%,成交量5.44万手,成交额1.12亿元。股本股东变化股东户数变动近日华兰疫苗披露,截至2026年2月13日公司股东户数为2.7万户,较1月31日减少1000.0户,减幅为3.57%。户均持股数量由上期的2.15万股增加至2.23万股,户均持股市值为46.7万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200000718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614835199","title":"华兰疫苗(301207)2月13日股东户数2.7万户,较上期减少3.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614835199","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614835199?lang=zh_cn&edition=full","pubTime":"2026-02-27 17:19","pubTimestamp":1772183997,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华兰疫苗披露,截至2026年2月13日公司股东户数为2.7万户,较1月31日减少1000.0户,减幅为3.57%。在生物制品行业个股中,华兰疫苗股东户数低于行业平均水平,截至2月13日,生物制品行业平均股东户数为3.47万户。从股价来看,2026年1月31日至2026年2月13日,华兰疫苗区间跌幅为4.38%,在此期间股东户数减少1000.0户,减幅为3.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700028779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614803599","title":"华兰疫苗(301207)披露募集资金专项账户部分资金被冻结及解除冻结的公告,2月25日股价上涨1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614803599","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614803599?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:36","pubTimestamp":1772030175,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘,华兰疫苗报收于21.24元,较前一交易日上涨1.14%,最新总市值为127.66亿元。近日,华兰生物疫苗股份有限公司发布《关于公司募集资金专项账户部分资金被冻结及解除冻结的公告》。公告显示,公司于2026年2月12日收到招商银行郑州分行通知,其募集资金专项账户部分资金被冻结,金额为1,409,065.28元,原因为采购合同纠纷。经与河南省新乡市中级人民法院沟通,该笔资金已于2026年2月13日全部解除冻结。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500038263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613579901","title":"华兰疫苗(301207)1月31日股东户数2.8万户,较上期增加27.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613579901","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613579901?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:27","pubTimestamp":1771925257,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华兰疫苗披露,截至2026年1月31日公司股东户数为2.8万户,较1月20日增加6000.0户,增幅为27.27%。在生物制品行业个股中,华兰疫苗股东户数低于行业平均水平,截至1月31日,生物制品行业平均股东户数为3.47万户。从股价来看,2026年1月20日至2026年1月31日,华兰疫苗区间涨幅为16.95%,在此期间股东户数增加6000.0户,增幅为27.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400032748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610680048","title":"华兰疫苗跌1.1% 2022年上市见顶募22.76亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610680048","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610680048?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:38","pubTimestamp":1770626297,"startTime":"0","endTime":"0","summary":"中国经济网北京2月9日讯 华兰疫苗 今日收报21.66元,跌幅1.10%。 上市首日,华兰疫苗盘中创下上市以来最高点79.78元。 华兰疫苗首次公开发行股票募集资金总额为22.76亿元,扣除含税发行费用3156.57万元,实际募集资金净额为22.44亿元。 2023年5月30日,华兰疫苗发布2022年年度权益分派实施公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260209/32007521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608885567","title":"股市必读:华兰疫苗(301207)1月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2608885567","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608885567?lang=zh_cn&edition=full","pubTime":"2026-02-02 01:13","pubTimestamp":1769965988,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,华兰疫苗报收于21.94元,下跌3.01%,换手率3.67%,成交量22.03万手,成交额4.89亿元。董秘最新回复投资者: 您好董秘:1、做为有责任敢担当的公司,公司如何实现价值回归?截至2026年1月20日,公司股东人数为两万两千余人,感谢您对公司的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200000561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607180600","title":"华兰疫苗:截至2026年1月20日,公司股东人数为两万两千余人","url":"https://stock-news.laohu8.com/highlight/detail?id=2607180600","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607180600?lang=zh_cn&edition=full","pubTime":"2026-01-30 17:05","pubTimestamp":1769763921,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰疫苗(301207)01月30日在投资者关系平台上答复投资者关心的问题。投资者提问:请问1月20日公司股东人数是多少?谢谢!华兰疫苗回复:尊敬的投资者您好!截至2026年1月20日,公司股东人数为两万两千余人,感谢您对公司的关注。为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260130/31986862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607702684","title":"华兰疫苗跌9.05% 2022年上市见顶募22.76亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607702684","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607702684?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:03","pubTimestamp":1769677401,"startTime":"0","endTime":"0","summary":"中国经济网北京1月29日讯 华兰疫苗 今日收报22.62元,跌幅9.05%。 上市首日,华兰疫苗盘中创下上市以来最高点79.78元。 华兰疫苗首次公开发行股票募集资金总额为22.76亿元,扣除含税发行费用3156.57万元,实际募集资金净额为22.44亿元。 2023年5月30日,华兰疫苗发布2022年年度权益分派实施公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260129/31983204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606886977","title":"华兰疫苗最新公告:公司尚无预防尼帕病毒相关的疫苗产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2606886977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606886977?lang=zh_cn&edition=full","pubTime":"2026-01-27 18:29","pubTimestamp":1769509791,"startTime":"0","endTime":"0","summary":"华兰疫苗(301207.SZ)公告称,公司股票连续三个交易日收盘价格涨幅偏离值累计超过30%,属于股票交易异常波动情况。公司所处的行业为人用疫苗制造业,主要产品为四价流感病毒疫苗,该产品用于预防因流感病毒引发的流行性感冒,目前公司尚无预防尼帕病毒相关的疫苗产品。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700032977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606136219","title":"1月26日华兰疫苗(301207)龙虎榜数据:机构净买入1652.12万元,北向资金净买入203.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606136219","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606136219?lang=zh_cn&edition=full","pubTime":"2026-01-26 18:27","pubTimestamp":1769423239,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年1月26日公布的交易公开信息显示,华兰疫苗因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年1月26日收盘,华兰疫苗报收于23.34元,上涨20.0%,涨停,换手率4.52%,成交量27.16万手,成交额6.01亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入1652.12万元,北向资金合计净买入203.06万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600025326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606726760","title":"异动快报:华兰疫苗(301207)1月26日9点57分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2606726760","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606726760?lang=zh_cn&edition=full","pubTime":"2026-01-26 10:00","pubTimestamp":1769392856,"startTime":"0","endTime":"0","summary":"证券之星1月26日盘中消息,9点57分华兰疫苗(301207)触及涨停板。其所属行业生物制品目前上涨。领涨股为华兰疫苗。该股为疫苗,流感,医药概念热股,当日疫苗概念上涨1.91%,流感概念上涨1.19%。1月23日的资金流向数据方面,主力资金净流入1224.56万元,占总成交额9.08%,游资资金净流出230.99万元,占总成交额1.71%,散户资金净流出993.57万元,占总成交额7.37%。近5日资金流向一览见下表:华兰疫苗主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600005415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603996907","title":"华兰疫苗跌2.3% 2022年上市见顶募22.76亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603996907","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603996907?lang=zh_cn&edition=full","pubTime":"2026-01-16 17:22","pubTimestamp":1768555322,"startTime":"0","endTime":"0","summary":"中国经济网北京1月16日讯 华兰疫苗 今日收报19.14元,跌幅2.30%。 上市首日,华兰疫苗盘中创下上市以来最高点79.78元。 华兰疫苗首次公开发行股票募集资金总额为22.76亿元,扣除含税发行费用3156.57万元,实际募集资金净额为22.44亿元。 2023年5月30日,华兰疫苗发布2022年年度权益分派实施公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260116/31948835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595127727","title":"流感疫情持续,防控系统工程再受考验","url":"https://stock-news.laohu8.com/highlight/detail?id=2595127727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595127727?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:18","pubTimestamp":1767172695,"startTime":"0","endTime":"0","summary":"2025年末,全国流感疫情持续处于高流行水平。产业链协同响应,构建多层次供应保障流感防控是一项系统工程,需要疫苗预防、快速诊断、药物治疗等多个环节的有效衔接。本轮疫情中,上市药企正通过全产业链布局,搭建从源头预防到终端治疗的健康保障网络。中成药在本轮疫情中表现活跃。公司表示,金振口服液四季度市场需求回暖,正加紧排产满足市场需要。随着该产品儿童流感新适应症的获批,其在儿科领域的应用场景进一步拓宽。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025123100030908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600079","BK0074","BK0028","BK0201","BK0187","600557","BK0060","688276","BK0196","BK0197","301207","BK0146","603882","SG9999001069.SGD","BK0077","BK0236","000756","BK0284","600566","002728","BK0070","002603","000999","BK0185","BK0175","BK0096","BK0010","BK0164","BK0097","BK0086","BK0188","300937","603858","BK0042","BK0012","002317","BK0186","BK0239","002393","000623","BK0183","BK0114","BK0250","BK0046","300244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595767102","title":"华兰疫苗:流感疫苗占公司营收比例超90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595767102","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595767102?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:12","pubTimestamp":1767082326,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰疫苗(301207)12月30日在投资者关系平台上答复投资者关心的问题。投资者提问:流感疫苗销售情况,其占公司营收比例华兰疫苗回复:尊敬的投资者您好!自今年10月份特别是11月份以来,民众接种流感疫苗的意识显著增强,公司流感疫苗特别是四价流感病毒裂解疫苗的库存消化较快,流感疫苗占公司营收比例超90%,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000022900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590583523","title":"华兰疫苗:流感疫苗批签发批次数量位居国内前列","url":"https://stock-news.laohu8.com/highlight/detail?id=2590583523","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590583523?lang=zh_cn&edition=full","pubTime":"2025-12-12 09:06","pubTimestamp":1765501571,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰疫苗(301207)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问董秘公司在流感疫苗市场中处于什么地位?华兰疫苗回复:尊敬的投资者您好,公司在流感疫苗生产和销售领域占据领先地位,具备年产一亿剂四价流感疫苗的产能,根据中国食品药品检定研究院的公开数据显示,截至目前公司已签发流感疫苗批次为55批,批签发批次数量位居国内前列。感谢您对公司的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200005219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586786209","title":"华兰疫苗:截至目前已签发流感疫苗55批","url":"https://stock-news.laohu8.com/highlight/detail?id=2586786209","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586786209?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:21","pubTimestamp":1764314481,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰疫苗(301207)11月28日在投资者关系平台上答复投资者关心的问题。投资者提问:金迪克今年共批下来11批疫苗,贵司批签了多少支流感疫苗?有一千万支吗?华兰疫苗回复:尊敬的投资者您好,根据中国食品药品检定研究院的公开数据显示,截至目前已签发流感疫苗批次为55批,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800016527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584564965","title":"华兰疫苗跌5.4% 2022年上市见顶募22.76亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584564965","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584564965?lang=zh_cn&edition=full","pubTime":"2025-11-17 17:49","pubTimestamp":1763372978,"startTime":"0","endTime":"0","summary":"中国经济网北京11月17日讯 华兰疫苗 今日收报24.01元,跌幅5.40%。 华兰疫苗于2022年2月18日在深交所创业板上市,公开发行的股票数量为4001.00万股,发行价格为56.88元/股,保荐机构为华泰联合证券有限责任公司,保荐代表人为贾鹏、刘晓宁。 华兰疫苗首次公开发行股票募集资金总额为22.76亿元,扣除含税发行费用3156.57万元,实际募集资金净额为22.44亿元。 2023年5月30日,华兰疫苗发布2022年年度权益分派实施公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20251117/31802081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","301207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579698196","title":"华兰疫苗:流感疫苗批签发批次数量居国内前列","url":"https://stock-news.laohu8.com/highlight/detail?id=2579698196","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579698196?lang=zh_cn&edition=full","pubTime":"2025-10-30 15:27","pubTimestamp":1761809232,"startTime":"0","endTime":"0","summary":"证券之星消息,华兰疫苗10月30日在投资者关系平台上答复投资者关心的问题。目前公司在研产品包括吸附无细胞百(三组分)白破联合疫苗、冻干b型流感嗜血杆菌结合疫苗等。公司将持续推进疫苗研发工作,丰富产品管线。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000023446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775100656401,"stockEarnings":[{"period":"1week","weight":0.0744},{"period":"1month","weight":0.0141},{"period":"3month","weight":0.0778},{"period":"6month","weight":0.1963},{"period":"1year","weight":0.1937},{"period":"ytd","weight":0.0778}],"compareEarnings":[{"period":"1week","weight":0.0043},{"period":"1month","weight":-0.056},{"period":"3month","weight":-0.0051},{"period":"6month","weight":0.0169},{"period":"1year","weight":0.1792},{"period":"ytd","weight":-0.0051}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华兰生物疫苗股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"26773人(较上一季度减少0.84%)","perCapita":"22434股","listingDate":"2022-02-18","address":"河南省新乡市红旗区华兰大道甲1号附1号","registeredCapital":"60102万元","survey":" 华兰生物疫苗股份有限公司的主营业务是人用疫苗研发、生产、销售。公司的主要产品是流感病毒裂解疫苗、四价流感病毒裂解疫苗、四价流感病毒裂解疫苗(儿童剂型)、甲型H1N1流感病毒裂解疫苗、ACYW135群脑膜炎球菌多糖疫苗、重组乙型肝炎疫苗(汉逊酵母)、A群C群脑膜炎球菌多糖疫苗、冻干人用狂犬病疫苗(Vero细胞)、吸附破伤风疫苗。公司核心产品的先发优势明显,公司研制出全球首批甲型H1N1流感病毒裂解疫苗,该产品获得国家科学技术部、国家质量监督检验检疫总局等机构联合颁发的“国家重点新产品”证书。","listedPrice":56.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华兰疫苗(301207)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华兰疫苗(301207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华兰疫苗,301207,华兰疫苗股票,华兰疫苗股票老虎,华兰疫苗股票老虎国际,华兰疫苗行情,华兰疫苗股票行情,华兰疫苗股价,华兰疫苗股市,华兰疫苗股票价格,华兰疫苗股票交易,华兰疫苗股票购买,华兰疫苗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华兰疫苗(301207)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华兰疫苗(301207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}